BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11361869)

  • 1. About the NDA filing.
    AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361869
    [No Abstract]   [Full Text] [Related]  

  • 2. NDA submitted for new formulation of saquinavir.
    AIDS Patient Care STDS; 1997 Aug; 11(4):288-9. PubMed ID: 11361847
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
    AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
    [No Abstract]   [Full Text] [Related]  

  • 4. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves SQV/r.
    IAPAC Mon; 2004 Jan; 10(1):39. PubMed ID: 15108675
    [No Abstract]   [Full Text] [Related]  

  • 6. Boosted saquinavir approved.
    AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642
    [No Abstract]   [Full Text] [Related]  

  • 7. Combo approved for HIV treatment.
    Nurse Pract; 2004 Mar; 29(3):40. PubMed ID: 15052701
    [No Abstract]   [Full Text] [Related]  

  • 8. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roche brings new formulation of saquinavir to FDA. Food and Drug Administration.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):8. PubMed ID: 11364377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why the old saquinavir (Invirase) may be bad for your health.
    Vazquez E
    Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent saquinavir get European nod.
    AIDS Patient Care STDS; 2005 Aug; 19(8):540. PubMed ID: 16163788
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 13. [A further option in PI therapy. Approval of a new protease inhibitor in the USA].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():30. PubMed ID: 16385868
    [No Abstract]   [Full Text] [Related]  

  • 14. Searching for the right dose of ritonavir-saquinavir.
    TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
    [No Abstract]   [Full Text] [Related]  

  • 15. Saquinavir switch study stopped.
    Treat Rev; 1997 Apr; (No 24):6. PubMed ID: 11364285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norvir capsule approved.
    AIDS Patient Care STDS; 1999 Sep; 13(9):567. PubMed ID: 10813038
    [No Abstract]   [Full Text] [Related]  

  • 17. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV agents. Saquinavir with fosamprenavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
    [No Abstract]   [Full Text] [Related]  

  • 20. Twice daily saquinavir.
    AIDS Patient Care STDS; 1999 May; 13(5):307. PubMed ID: 10356812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.